Harris Accepts Presidential Nomination | SpaceX Attempts First Commercial Spacewalk | New Pill Shows Promise in Easing Menopause Symptom

Vice President Kamala Harris made history by accepting the presidential nomination on the last night of the 2024 Democratic National Convention. The night was filled with powerful speeches, celebrations and highlighted Harris' path to the DNC stage. CBS News political contributor Joel Payne breaks down the key moments from the final night of the 2024 Democratic National Convention. Before Vice President Kamala Harris delivered her DNC speech in Chicago, "CBS Mornings" co-host Tony Dokoupil spoke with convention delegates about her policies. Even though she is the nominee, many said they weren't sure about her positions on key issues. CBS News' Confirmed team dives into Vice President Kamala Harris' key statements from her nomination speech. They break down her claims on issues like the national debt and tariffs, revealing which are true and which are misleading. Four astronauts are set to launch on Tuesday for a groundbreaking six-day mission, "Polaris Dawn," aiming to reach a record orbit 870 miles above Earth—three times higher than the International Space Station. The mission will also feature the first-ever commercial spacewalk. Mark Strassmann met the crew, who have trained for two years for this historic journey. A new experimental pill may relieve hot flashes, a common menopause symptom experienced by over 75% of women. Unlike other treatments, this pill does not use hormones. CBS News medical contributor Dr. Celine Gounder explains the potential impact on women's health. Hannah Berner and Paige DeSorbo, hosts of the popular "Giggly Squad" podcast, join "CBS Mornings" to talk about how they went from recording Instagram Live videos during the pandemic to hosting one of the most downloaded podcasts on Apple. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices